Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs

Figure 1

Antibody levels for serotype 6B at vaccination, at 4 to 6 weeks after vaccination, and at 1.5-year follow-up in patients with rheumatoid arthritis (RA) and spondyloarthropathy (SpA) treated with different antiinflammatory drugs. Antibody levels ≥1 mg/L were considered putative protective (short dashed line).

Back to article page